Women | Disease duration | Fat tissue (%) | Lean tissue (%) | BMC(%) | DAS28 |
---|---|---|---|---|---|
Glucocorticoids | 0,29 | 0,46 | -0,44 | -0,50* | 0,53* |
Disease duration (yrs) | Â | 0,46 | -0,45 | -0,48* | -0,27 |
Fat tissue (%) | Â | Â | -1.00*** | -0,64*** | 0,05 |
Lean tissue (%) | Â | Â | Â | 0,61** | -0,04 |
BMC (%) | Â | Â | Â | Â | -0,13 |
Men | Disease duration | Fat tissue (%) | Lean tissue (%) | BMC (%) | DAS28 |
Glucocorticoids | -0,16 | 0,33 | -0,34 | -0,23 | 0,32 |
Disease duration (years) | Â | 0,31 | -0,31 | -0,27 | -0,02 |
Fat tissue (%) | Â | Â | -1.00*** | -0,83*** | -0,04 |
Lean tissue (%) | Â | Â | Â | 0,81** | 0,04 |
BMC (%) | Â | Â | Â | Â | -0,10 |